We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Cornea Improves Children's Vision

By HospiMedica staff writers
Posted on 19 Jan 2007
An artificial cornea offers better results for infants for whom traditional cornea transplants usually fail. More...


Researchers at the University of Rochester Eye Institute (Rochester, NY, USA) and a colleague at Johns Hopkins University (Baltimore, MD, USA) conducted a study that included 17 children who underwent 23 implant procedures of a device known as the Boston Keratoprosthesis. The patients had collectively been through more than 100 previous surgical procedures--including 39 traditional cornea transplants that had failed--before the latest implant. Fifteen of the children received the Boston device, while another two received a different type of artificial implant that consequently failed. All 15 children who received the Boston implant recovered some vision, sometimes remarkably so, and none had any problem or infection with the implant. In the seven cases where the child was 4 years old or older and could explain to some degree how much he or she could see, every child could at least see fingers held at an arm's length, and some children improved to 20/30 vision. The results were presented at the 2006 annual meeting of the American Academy of Ophthalmology, held in Las Vegas (NV, USA) during December 2006.

"Finally, we seem to have a method in hand to improve the vision of these children, many of whom have endured several surgeries that have failed,” said lead author James Aquavella, M.D., a University of Rochester ophthalmologist. "These are children for whom, until now, there really has not been a good option. It's either do this, or do nothing.”

The Boston keratoprosthesis consists of two plastic parts that together clamp a corneal graft; when fully assembled, it has the shape of a collar button. The device is made of a new type of plastic that allows nutrients to enter the eye more quickly than previous designs. The latest procedure also includes a large contact lens placed over the cornea to help protect it from inflammation and scarring. After the procedure patients use antibiotic eye drops each day for the rest of their lives to prevent infection.



Related Links:
University of Rochester Eye Institute
Johns Hopkins University

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.